Literature DB >> 20684211

[A case of repeated bilateral pneumothorax associated with upper lobe predominant fibrosis in an aluminum processing worker].

Kanako Inuzuka1, Masahide Yasui, Yuko Waseda, Hazuki Takato, Yukari Ichikawa, Masaki Fujimura.   

Abstract

A 39-year-old man, who had been working in an aluminum processing industry for 18 years, visited our hospital for right chest pain on March 2, 2007. A relapse of right pneumothorax was found, and he was hospitalized. As the pneumothorax did not improve with conservative treatment, video-assisted thoracoscopic biopsy and suturing of the right upper lobe were successfully performed. The pulmonary parenchyma had collapsed, there was pulmonary fibrosis, and lymphocytes had gathered in follicules. Based on elemental analysis results, we diagnosed aluminum lung. It was thought that overexpansion of the lower lobe with the predominant upper lobe fibrosis was caused by the aluminum deposition. We judged his condition to be serious and we started treatment with 25 mg/day prednisolone (PSL), and 120 mg/day cyclosporine (CyA). At the time of writing, he is an outpatient, and is being monitored on a regimen of 5 mg/day PSL and 160 mg/day CyA without any progression of pulmonary fibrosis or relapse of pneumothorax.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20684211

Source DB:  PubMed          Journal:  Nihon Kokyuki Gakkai Zasshi        ISSN: 1343-3490


  3 in total

1.  Pleuroparenchymal Fibroelastosis: Its Clinical Characteristics.

Authors:  Kentaro Watanabe
Journal:  Curr Respir Med Rev       Date:  2013-06

2.  Bilateral Tuberculous Pleurisy with Subsequent Upper Lobe Predominant Pulmonary Fibrosis Mimicking Pleuroparenchymal Fibroelastosis.

Authors:  Takako Kawaguchi; Keishi Oda; Takashi Kido; Toshinori Kawanami; Yoshinori Kawabata; Kazuhiro Yatera
Journal:  Intern Med       Date:  2017-10-16       Impact factor: 1.271

3.  The similarities and differences between pleuroparenchymal fibroelastosis and idiopathic pulmonary fibrosis.

Authors:  Hiroshi Ishii; Yoshiaki Kinoshita; Hisako Kushima; Nobuhiko Nagata; Kentaro Watanabe
Journal:  Chron Respir Dis       Date:  2019 Jan-Dec       Impact factor: 2.444

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.